These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1312677)

  • 1. Plasmapheresis in chronic demyelinating polyneuropathy.
    Wallack EM
    N Engl J Med; 1992 Apr; 326(16):1090. PubMed ID: 1312677
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral neuropathy in osteosclerotic myeloma: clinical and electrodiagnostic improvement with chemotherapy.
    Donofrio PD; Albers JW; Greenberg HS; Mitchell BS
    Muscle Nerve; 1984 Feb; 7(2):137-41. PubMed ID: 6325905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of peripheral neuropathy with chemotherapy in osteosclerotic myeloma.
    Parra R; Fernandez JM; Garcia-Bragado F; Bueno J; Biosca M
    J Neurol; 1987 May; 234(4):261-3. PubMed ID: 3039073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudohypercalcemia and hyperviscosity with neurological manifestations in multiple myeloma.
    van Dijk JM; Sonnenblick M; Weissberg N; Rosin A
    Isr J Med Sci; 1986 Feb; 22(2):143-4. PubMed ID: 3753959
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of peripheral neuropathies in a case of IgA myeloma and one of mixed cryoglobulinaemia. Repeated plasmapheresis (author's transl)].
    Betourné C; Buge A; Dechy H; Dorra M; Dournon E; Rancurel G
    Nouv Presse Med; 1980 Apr; 9(19):1369-71. PubMed ID: 6247702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic plasmapheresis in patients with multiple myeloma].
    Mendek-Czajkowska E; Kraj M; Pogłód R; Rostkowska J; Maj S; Sabliński J
    Acta Haematol Pol; 1991; 22(1):31-41. PubMed ID: 1823964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic efficacy of VBCMP-M2 protocol in multiple myeloma.
    Colović MD; Janković GM; Nikolov VS; Suvajdzić ND; Miletić VD
    Haematologia (Budap); 1994; 26(2):91-6. PubMed ID: 7890267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and survival in multiple myeloma. Analysis of 91 cases treated by melphalan and prednisone.
    Gobbi M; Cavo M; Savelli G; Baccarani M; Tura S
    Haematologica; 1980 Aug; 65(4):437-45. PubMed ID: 6774915
    [No Abstract]   [Full Text] [Related]  

  • 9. Alternating intravenous courses of melphalan and peptichemio in high-risk multiple myeloma (preliminary results).
    Franchi F; Seminara P; Rossi Fanelli F
    Anticancer Res; 1986; 6(2):297-8. PubMed ID: 3707066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmapheresis in chronic demyelinating polyneuropathy.
    Toyka KV; Hartung HP; Steck A
    N Engl J Med; 1992 Apr; 326(16):1090-1. PubMed ID: 1312678
    [No Abstract]   [Full Text] [Related]  

  • 11. Osteosclerotic myeloma and peripheral neuropathy.
    Kelly JJ; Kyle RA; Miles JM; Dyck PJ
    Neurology; 1983 Feb; 33(2):202-10. PubMed ID: 6296727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of plasmapheresis in patients with AIDS and peripheral polyneuropathy].
    Lapiński TW; Prokopowicz D
    Pol Merkur Lekarski; 1999 Nov; 7(41):215-7. PubMed ID: 10680453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasmapheresis in the treatment of diphtheritic polyneuropathy].
    Postnikov AA; Sonina EI
    Klin Med (Mosk); 1995; 73(6):54-5. PubMed ID: 8691785
    [No Abstract]   [Full Text] [Related]  

  • 14. Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical study.
    Cavo M; Benni M; Ronconi S; Fiacchini M; Gozzetti A; Zamagni E; Cellini C; Tosi P; Baccarani M; Tura S;
    Haematologica; 2002 Sep; 87(9):934-42. PubMed ID: 12217805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term plasmapheresis therapy is effective and safe in children with chronic relapsing dysimmune polyneuropathy.
    Beydoun SR; Engel WK; Karofsky P; Schwartz MU
    Rev Neurol (Paris); 1990; 146(2):123-7. PubMed ID: 2157270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kidney diseases associated with multiple myeloma].
    Osawa G
    Nihon Naika Gakkai Zasshi; 1992 Jan; 81(1):49-52. PubMed ID: 1556462
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy versus melphalan and prednisone in multiple myeloma.
    Gruber A; Osby E
    Chemioterapia; 1987 Jun; 6(2 Suppl):725-6. PubMed ID: 3509531
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple complications in multiple myeloma.
    Basi S; Schulman G; Fogo AB
    Am J Kidney Dis; 2005 Mar; 45(3):619-23. PubMed ID: 15754288
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic experiences in multiple myeloma].
    Sonntag R; Favre E; Martz G
    Schweiz Med Wochenschr; 1972 Nov; 102(44):1588-9. PubMed ID: 4566555
    [No Abstract]   [Full Text] [Related]  

  • 20. Acquired demyelinative polyneuropathy: diagnosis and treatment with special reference to immunosuppressive therapy.
    Streib EW; Sun SF
    Nebr Med J; 1984 Mar; 69(3):60-3. PubMed ID: 6325956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.